Raphin1 is primarily studied for its potential therapeutic applications in the treatment of neurodegenerative diseases, particularly Huntington's disease. It functions by modulating the activity of specific cellular pathways that are involved in protein misfolding and aggregation, which are key pathological features of such conditions. By enhancing the cell's ability to manage these misfolded proteins, Raphin1 may help to slow disease progression and alleviate symptoms. Research is ongoing to further understand its efficacy and safety in clinical settings.